Viewing Study NCT03472560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-01-04 @ 11:41 PM
Study NCT ID: NCT03472560
Status: TERMINATED
Last Update Posted: 2024-04-09
First Post: 2018-02-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
None Urothelial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None non-small cell lung cancer View
None non small cell lung cancer View
None NSCLC View
None lung cancer View
None urothelial cancer View
None bladder cancer View
None Avelumab View
None Bavencio View
None Axitinib View
None Inlyta View